Johnson & Johnson vaccine hits production snags - POLITICO
By Sarah Owermohle & Adam Cancryn
J&J's one-shot Covid vaccine is safe and generates promising immune response in early trial
By Berkeley Lovelace & Berkeley Lovelace Jr.
J&J Sees Decision on Vaccine Clearance Coming by March
By Riley Griffin & John Tozzi
Johnson & Johnson Expects Vaccine Results Soon but Lags in Production (Published 2021)
By Sharon LaFraniere, Carl Zimmer & Noah Mercer Weiland